The Evofem team is proud to announce that we have resubmitted the NDA for our innovative, non-hormonal #contraceptive! This is tremendous milestone for the team and a significant step forward for the millions of women who are dissatisfied with their current contraceptive options
and are awaiting a new alternative. Read more here: https://evofem.investorroom.com/2019-11-26-Evofem-Biosciences-Resubmits-New-Drug-Application-to-U-S-FDA-for-Amphora-R-for-the-Prevention-of-Pregnancy …